| Literature DB >> 35956498 |
Valentina Picchi1, Antonella Calzone1, Serena Gobbi2, Sara Paccani1,2, Roberto Lo Scalzo1, Alessandra Marti2, Franco Faoro3.
Abstract
In our previous work, durum wheat cv. Fabulis was grown over two consecutive seasons (2016-2017 and 2017-2018) in an experimental field in the north of Italy. With the aim of mitigating oxidative stress, plants were subjected to four treatments (deionized water, CHT 0.05 mg/mL, CHT-NPs, and CHT-NPs-NAC) three times during the experiment. Chitosan nanoparticles (CHT-NPs) reduced symptom severity on wheat leaves and positively influenced the final grain yield. The present work aimed at investigating whether CHT treatments and particularly N-acetyl cysteine (NAC)-loaded or -unloaded CHT-NPs, while triggering plant defense mechanisms, might also vary the nutritional and technological quality of grains. For this purpose, the grains harvested from the previous experiment were analyzed for their content in phytochemicals and for their technological properties. The results showed that CHT increased the polyphenol and tocopherol content and the reducing capacity of bran and semolina, even if the positive effect of the nano-formulation remained still unclear and slightly varied between the two years of cultivation. The positive effect against oxidative stress induced by the chitosan treatments was more evident in the preservation of both the starch pasting properties and gluten aggregation capacity, indicating that the overall technological quality of semolina was maintained. Our data confirm the role of chitosan as an elicitor of the antioxidant defense system in wheat also at the grain level.Entities:
Keywords: chitosan; durum wheat; nanoparticles; oxidative stress; polyphenols; semolina; tocols
Year: 2022 PMID: 35956498 PMCID: PMC9370655 DOI: 10.3390/plants11152021
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Phenolic acid content (mg/100 g) in bran and semolina obtained from Triticum durum (cv. Fabulis) in 2017 and 2018, untreated (Ctrl) or treated with CHT, CHT-NPs, or CHT-NPs-NAC. All data are reported as mean ± standard deviation (n = 3) a.
| FA | VA | SYR | CA | p-CA | SA | ||
|---|---|---|---|---|---|---|---|
|
|
| ||||||
| Ctrl | 344.2 ± 25.8 a | 8.01 ± 0.06 b | 13.30 ± 0.74 a | 2.00 ± 0.33 | 8.01 ± 0.99 | 35.70 ± 2.61 a | |
| CHT | 425.9 ± 23.0 b | 8.83 ± 0.02 c | 18.06 ± 1.94 b | 2.49 ± 0.13 | 8.83 ± 1.06 | 43.99 ± 2.81 b | |
| CHT-NPs | 386.2 ± 37.5 ab | 7.68 ± 0.59 a | 12.30 ± 0.52 a | 2.20 ± 0.45 | 7.68 ± 0.89 | 41.98 ± 2.39 b | |
| CHT-NPs-NAC | 414.5 ± 52.3 b | 8.97 ± 0.22 d | 17.92 ± 3.08 b | 1.98 ± 0.50 | 8.97 ± 0.99 | 45.72 ± 3.12 b | |
|
|
|
|
|
|
|
| |
|
| |||||||
| Ctrl | 28.3 ± 0.8 | 0.79 ± 0.04 | 1.79 ± 0.13 | 0.17 ± 0.04 | 0.79 ± 0.12 b | 5.23 ± 0.43 | |
| CHT | 28.8 ± 2.5 | 0.68 ± 0.14 | 1.54 ± 0.03 | 0.18 ± 0.06 | 0.68 ± 0.02 ab | 4.96 ± 0.60 | |
| CHT-NPs | 30.1 ± 3.0 | 0.68 ± 0.10 | 1.54 ± 0.29 | 0.17 ± 0.00 | 0.68 ± 0.07 ab | 5.68 ± 0.75 | |
| CHT-NPs-NAC | 25.6 ± 1.4 | 0.59 ± 0.17 | 1.56 ± 0.28 | 0.13 ± 0.04 | 0.59 ± 0.02 a | 4.58 ± 0.40 | |
|
|
|
|
|
|
|
| |
|
|
| ||||||
| Ctrl | 194.5 ± 7.4 a | 4.69 ± 0.33 a | 1.77 ± 0.05 a | 0.87 ± 0.07 | 5.81 ± 0.60 ab | 24.41 ± 1.13 a | |
| CHT | 264.1 ± 25.8 b | 5.38 ± 0.47 b | 2.51 ± 0.03 b | 0.91 ± 0.10 | 8.38 ± 2.13 b | 31.65 ± 3.53 b | |
| CHT-NPs | 261.3 ± 3.7 b | 5.81 ± 0.50 b | 2.27 ± 0.12 ab | 0.73 ± 0.21 | 4.69 ± 1.16 a | 30.64 ± 0.68 b | |
| CHT-NPs-NAC | 275.9 ± 19.3 b | 5.12 ± 0.80 b | 2.58 ± 0.25 b | 1.02 ± 0.21 | 5.12 ± 2.34 a | 37.08 ± 0.91 c | |
|
|
|
|
|
|
|
| |
|
| |||||||
| Ctrl | 26.3 ± 2.7 | 0.49 ± 0.13 a | 0.50 ± 0.06 a | 0.11 ± 0.04 ab | 0.64 ± 0.03 | 5.80 ± 0.60 | |
| CHT | 27.7 ± 2.5 | 0.52 ± 0.06 b | 0.60 ± 0.08 ab | 0.05 ± 0.02 a | 0.49 ± 0.05 | 5.76 ± 0.24 | |
| CHT-NPs | 29.4 ± 6.9 | 0.50 ± 0.07 a | 0.56 ± 0.12 b | 0.07 ± 0.02 a | 0.50 ± 0.13 | 6.76 ± 1.09 | |
| CHT-NPs-NAC | 29.9 ± 4.6 | 0.64 ± 0.04 c | 0.63 ± 0.02 b | 0.14 ± 0.06 b | 0.52 ± 0.17 | 6.85 ± 1.11 | |
|
|
|
|
|
|
|
| |
a FA, ferulic acid; VA, vanillic acid; SYR, syringic acid; CA, caffeic acid; p-CA, p-coumaric acid; SA, sinapic acid. For each year, asterisks show the significance of treatments in both bran and semolina, following the one-way ANOVA: ***: p < 0.001; **: p < 0.01; *: p < 0.05; ns: not significant. Different letters indicate significant differences among treatments according to Tukey’s post-hoc test.
Figure 1Content of total polyphenols, carotenoids, and total reducing capacity in bran and semolina obtained from Triticum durum (cv. Fabulis) in 2017 (a,c,e) and 2018 (b,d,f), untreated (Ctrl) or treated with CHT, CHT-NPs, or CHT-NPs-NAC. Bars represent mean ± standard deviation (n = 3). Different uppercase and lowercase letters indicate significant differences among treatments in bran and semolina, respectively, according to Tukey’s post-hoc test.
Tocopherol and tocotrienol content (mg/100 g) in bran and semolina obtained from Triticum durum (cv. Fabulis) in 2017 and 2018, untreated (Ctrl) or treated with CHT, CHT-NPs, or CHT-NPs-NAC. All data are reported as mean ± standard deviation (n = 3) a.
| (β + γ)-T3 | α-T3 | (β + γ)-T | α-T | Total T3 | Total T | ||
|---|---|---|---|---|---|---|---|
|
|
| ||||||
| Ctrl | 11.85 ± 0.95 b | 0.49 ± 0.01 | 1.40 ± 0.09 a | 0.76 ± 0.13 | 12.33 ± 0.99 | 2.16 ± 0.04 a | |
| CHT | 14.25 ± 0.07 c | 0.55 ± 0.06 | 2.06 ± 0.01 b | 1.35 ± 0.00 | 14.80 ± 0.01 | 3.41 ± 0.01 bc | |
| CHT-NPs | 10.11 ± 1.02 a | 0.26 ± 0.01 | 1.39 ± 0.31 a | 1.04 ± 0.23 | 10.37 ± 1.03 | 2.43 ± 0.54 ab | |
| CHT-NPs-NAC | 12.55 ± 1.15 c | 0.29 ± 0.02 | 2.58 ± 0.38 c | 1.58 ± 0.77 | 12.98 ± 1.17 | 4.16 ± 1.03 c | |
|
|
|
|
|
|
|
| |
|
| |||||||
| Ctrl | 4.35 ± 0.38 a | 0.04 ± 0.01 | 0.68 ± 0.02 | 0.23 ± 0.02 a | 4.39 ± 0.38 a | 0.91 ± 0.03 a | |
| CHT | 4.02 ± 0.72 a | 0.15 ± 0.21 | 0.63 ± 0.09 | 0.23 ± 0.02 a | 4.17 ± 0.87 a | 0.86 ± 0.11 a | |
| CHT-NPs | 4.22 ± 0.51 a | 0.04 ± 0.01 | 0.55 ± 0.12 | 0.30 ± 0.03 b | 4.26 ± 0.52 a | 0.85 ± 0.14 a | |
| CHT-NPs-NAC | 5.50 ± 0.21 b | 0.03 ± 0.01 | 0.78 ± 0.02 | 0.32 ± 0.01 b | 5.53 ± 0.21 b | 1.10 ± 0.01 b | |
|
|
|
|
|
|
|
| |
|
|
| ||||||
| Ctrl | 7.53 ± 0.46 a | 0.30 ± 0.02 ab | 0.42 ± 0.03 | 0.32 ± 0.03 b | 7.83 ± 0.44 a | 0.74 ± 0.01 b | |
| CHT | 8.26 ± 0.17 b | 0.36 ± 0.03 bc | 0.50 ± 0.04 | 0.30 ± 0.04 b | 8.62 ± 0.18 b | 0.81 ± 0.08 c | |
| CHT-NPs | 9.31 ± 0.48 c | 0.36 ± 0.01 c | 0.48 ± 0.05 | 0.33 ± 0.02 b | 9.67 ± 0.48 c | 0.82 ± 0.07 c | |
| CHT-NPs-NAC | 8.20 ± 0.31 ab | 0.25 ± 0.04 a | 0.37 ± 0.01 | 0.16 ± 0.02 a | 8.45 ± 0.35 ab | 0.52 ± 0.01 a | |
|
|
|
|
|
|
|
| |
|
| |||||||
| Ctrl | 3.50 ± 0.09 a | 0.07 ± 0.01 a | 0.97 ± 0.05 | 0.52 ± 0.08 b | 3.57 ± 0.09 a | 1.49 ± 0.11 b | |
| CHT | 4.76 ± 0.05 b | 0.07 ± 0.01 ab | 1.16 ± 0.08 | 0.49 ± 0.01 b | 4.83 ± 0.06 b | 1.66 ± 0.09 c | |
| CHT-NPs | 4.29 ± 0.11 b | 0.11 ± 0.01 b | 0.95 ± 0.05 | 0.68 ± 0.08 c | 4.40 ± 0.11 b | 1.64 ± 0.05 c | |
| CHT-NPs-NAC | 3.50 ± 0.01 a | 0.06 ± 0.02 a | 0.88 ± 0.03 | 0.24 ± 0.10 a | 3.56 ± 0.03 a | 1.12 ± 0.08 a | |
|
|
|
|
|
|
|
| |
a (β + γ)-T3, (β + γ)-Tocotrienols; α-T3, α-Tocotrienol; (β + γ)-T, (β + γ)-Tocopherols; α-T, α-Tocopherol; Total T3, total tocotrienols; Total-T, total tocopherols. For each year, asterisks show the significance of treatments in both bran and semolina, following the one-way ANOVA: **: p < 0.01; *: p < 0.05; ns: not significant. Different letters indicate significant differences among treatments according to Tukey’s post-hoc test.
Total and damaged starch (g/100 g db) and pasting properties of semolina obtained from Triticum durum (cv. Fabulis) in 2017 and 2018, untreated (Ctrl) or treated with CHT, CHT-NPs, or CHT-NPs-NAC. All data are reported as mean ± standard deviation (n = 3) a.
| Total Starch | Damaged Starch | Beginning of Gelatinization | Maximum Viscosity | End of Final Holding Period | Breakdown | Setback | ||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Ctrl | 71.34 ± 3.18 | 11.00 ± 0.52 | 64.87 ± 0.23 | 235.67 ± 8.08 | 650.33 ± 23.29 | 35.00 ± 1.73 | 461.00 ± 22.52 | |
| CHT | 71.71 ± 2.69 | 11.36 ± 0.08 | 65.50 ± 0.46 | 232.00 ± 15.87 | 641.00 ± 47.03 | 37.67 ± 2.08 | 458.67 ± 28.31 | |
| CHT-NPs | 72.22 ± 4.38 | 11.01 ± 0.67 | 65.00 ± 0.52 | 237.33 ± 10.41 | 668.67 ± 38.48 | 35.67 ± 1.53 | 476.67 ± 29.94 | |
| CHT-NPs-NAC | 72.76 ± 2.81 | 11.43 ± 0.42 | 65.17 ± 0.40 | 227.33 ± 6.66 | 643.33 ± 19.35 | 33.67 ± 2.52 | 457.33 ± 14.57 | |
|
|
|
|
|
|
|
|
| |
|
| ||||||||
| Ctrl | 67.78 ± 1.77 | 7.18 ± 0.50 | 65.46 ± 1.08 ab | 183.88 ± 11.86 | 414.38 ± 25.60 | 48.86 ± 2.04 | 285.75 ± 17.98 | |
| CHT | 67.16 ± 2.21 | 7.33 ± 0.40 | 66.19 ± 0.72 ab | 176.63 ± 8.94 | 405.50 ± 13.26 | 44.50 ± 4.21 | 277.88 ± 12.16 | |
| CHT-NPs | 66.99 ± 1.21 | 7.54 ± 0.51 | 66.58 ± 1.51 b | 169.63 ± 12.37 | 378.13 ± 31.42 | 46.63 ± 3.81 | 259.63 ± 22.92 | |
| CHT-NPs-NAC | 66.98 ± 0.79 | 7.34 ± 0.24 | 64.53 ± 1.34 a | 178.00 ± 20.33 | 401.25 ± 57.81 | 45.88 ± 5.22 | 273.25 ± 42.46 | |
|
|
|
|
|
|
|
|
| |
a db, dry basis; beginning of gelatinization (°C), temperature at which an initial increase in viscosity occurs; maximum viscosity (BU, Brabender Unit), maximum viscosity reached during the analysis; end of final holding period (BU); breakdown (BU), difference between the maximum viscosity and the viscosity reached at the end of the holding period; setback (BU), difference between the final viscosity and the viscosity reached at the end of the holding period. For each year, asterisks show the significance of treatments in both bran and semolina, following the one-way ANOVA: *: p < 0.05; ns: not significant. Different letters indicate significant differences among treatments according to Tukey’s post-hoc test.
Thiols (mg GSH/100 g), total proteins (g/100 g db), and gluten aggregation properties of semolina obtained from Triticum durum (cv. Fabulis) in 2017 and 2018, untreated (Ctrl) or treated with CHT, CHT-NPs, or CHT-NPs-NAC. All data are reported as mean ± standard deviation (n = 3) a.
| Thiols | Total Proteins | Peak Maximum Time | Maximum Torque | ||
|---|---|---|---|---|---|
|
| |||||
| Ctrl | 25.14 ± 3.76 | 13.69 ± 0.68 | 40.57 ± 2.37 | 50.91 ± 3.07 | |
| CHT | 23.05 ± 0.92 | 13.77 ± 0.38 | 38.17 ± 2.14 | 51.80 ± 3.51 | |
| CHT-NPs | 22.89 ± 2.88 | 13.33 ± 0.77 | 44.50 ± 3.73 | 48.67 ± 3.07 | |
| CHT-NPs-NAC | 20.72 ± 2.46 | 13.97 ± 0.23 | 37.17 ± 1.72 | 54.50 ± 1.50 | |
|
|
|
|
|
| |
|
| |||||
| Ctrl | 18.48 ± 0.88 | 13.77 ± 0.09 | 35.56 ± 2.60 a | 50.80 ± 1.47 a | |
| CHT | 22.81 ± 5.83 | 13.98 ± 0.05 | 33.50 ± 2.22 a | 52.38 ± 1.12 ab | |
| CHT-NPs | 20.66 ± 0.65 | 14.00 ± 0.22 | 34.55 ± 2.62 a | 53.13 ± 2.38 b | |
| CHT-NPs-NAC | 19.01 ± 1.51 | 13.92 ± 0.27 | 37.00 ± 2.39 a | 52.90 ± 1.56 b | |
|
|
|
|
|
| |
a db, dry basis; peak maximum time, expressed in seconds, corresponds to the peak torque time; maximum torque, expressed in Brabender Equivalents (BE), corresponds to the peak that occurs when gluten aggregates. *: p < 0.05; ns: not significant. Different letters indicate significant differences among treatments according to Tukey’s post-hoc test.